Amundi
AGL icon

Amundi’s Agilon Health AGL Stock Holding History

Amundi’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-78,772
Closed -$1.36M – 2035
2025
Q4 		$1.36M Buy
+78,772
New +$1.53M ﹤0.01% 1216
2025
Q3 		– Sell
-71,824
Closed -$4.29M – 1590
2025
Q2 		$4.29M Buy
71,824
+12,436
+21% +$997K ﹤0.01% 951
2025
Q1 		$5.94M Buy
59,388
+19,576
+49% +$1.7M ﹤0.01% 926
2024
Q4 		$2.18M Buy
39,812
+1,139
+3% +$68.9K ﹤0.01% 1171
2024
Q3 		$3.05M Buy
38,673
+38,639
+113,644% +$4.99M ﹤0.01% 1076
2024
Q2 		$5.1K Sell
34
-29,472
-100% -$4.2M ﹤0.01% 1887
2024
Q1 		$3.97M Sell
29,506
-16,730
-36% -$2.78M ﹤0.01% 1009
2023
Q4 		$9.76M Buy
46,236
+5,116
+12% +$1.85M ﹤0.01% 848
2023
Q3 		$18.7M Buy
41,120
+15,343
+60% +$6.93M 0.01% 703
2023
Q2 		$10.9M Sell
25,777
-16,838
-40% -$9.46M 0.01% 830
2023
Q1 		$27.6M Buy
42,615
+2,060
+5% +$1.15M 0.01% 644
2022
Q4 		$19.4M Buy
40,555
+11,994
+42% +$5.62M 0.01% 703
2022
Q3 		$17.1M Sell
28,561
-13,675
-32% -$8.19M 0.01% 731
2022
Q2 		$27.4M Buy
42,236
+12,869
+44% +$6.51M 0.02% 559
2022
Q1 		$18.2M Buy
29,367
+3,748
+15% +$1.93M 0.01% 694
2021
Q4 		$13.2M Buy
25,619
+24,192
+1,695% +$14.7M 0.01% 777
2021
Q3 		$935K Buy
+1,427
New +$1.22M ﹤0.01% 1304

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Amundi's AGL Position: Q1 2026 in Review

Amundi sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 78,772 shares — an estimated $1.36M sold.

Amundi first reported a position in AGL in Q3 2021 and held it in 17 quarters. The position peaked at $27.6M in Q1 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Amundi reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Amundi sold 78,772 Agilon Health shares in Q1 2026, an estimated $1.36M.
  • Amundi first reported a position in Agilon Health in Q3 2021 and held it in 17 quarters.
  • Amundi's Agilon Health position peaked at $27.6M in Q1 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.